Cell aggregation by scaffolded receptor clusters

Chemistry and Biology

Volumn 9, Issue 2, 2002, Pages 163-169

  Gestwicki, Jason E ^b   Strong, Laura E ^a   Cairo, Christopher W ^a   Boehm, Frederick J ^a   Kiessling, Laura L ^a,b  

^a Department of Chemistry ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CONCANAVALIN A RECEPTOR;

ARTICLE; CELL AGGREGATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENERGY TRANSFER; HUMAN; LEUKEMIA CELL LINE; MACROMOLECULE; PROTEIN FOLDING;

CELL AGGREGATION; CONCANAVALIN A; ENERGY TRANSFER; HUMANS; JURKAT CELLS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; PROTEIN FOLDING; RECEPTORS, CONCANAVALIN A;

EID: 0036008843     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00102-3     Document Type: Article

References (53)

1. Autologous red cell agglutination assay for HIV-1 antibodies: Simplified test with whole blood
2. Agglutinins from aquatic insects-tumor cell agglutination activity
3. Design and production of novel tetravalent bispecific antibodies
4. Bispecific antibodies in cancer therapy
5. Clearance of blood-borne pathogens mediated through bispecific monoclonal antibodies bound to the primate erythrocyte complement receptor
6. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: Multimerization effect on cell agglutination and application to blood typing
7. Lectins: Sources, activities, and applications
8. Cell hybridization and cell agglutination 1. Enhancement of cell hybridization by lectins
9. Continuous antibody production by phytohemagglutinin-L-aggregated hybridoma cells
10. Bispecific monoclonal antibody complexes facilitate eryhthrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model
11. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model
12. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies
13. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with model pathogen
14. The influence of polyvalency on the binding properties of antibodies
15. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
16. Strength in numbers: Non-natural polyvalent carbohydrate derivatives
17. High avidity scFv multimers; diabodies and triabodies
18. Design and application of diabodies, tribodies, and tetrabodies for cancer targeting
19. Dual mechanism of protein-tyrosine phosphorylation in concanavalin A-stimulated platelets
20. Cross-linked derivatives of concanavalin A
21. Multivalent protein-carbohydrate interactions: A new paradigm for supermolecular assembly and signal transduction
22. The C-type lectin superfamily in the immune system
23. Lectins: Carbohydrate-specific proteins that mediate cellular recognition
24. GlcNAc-terminated glycodendrimers form defined precipitates with the soluble dimeric receptor of rat natural killer cells, sNKR-P1A
25. Synthesis of per-glycosylated β-cyclodextrins having enhanced lectin binding affinity
26. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
27. Multivalency effects in protein-carbohydrate interaction: The binding of the Shiga-like toxin 1 binding subunit to multivalent C-linked glycopeptides
28. Synergistic formation of soluble lectin clusters by a templated multivalent saccharide ligand
29. On the meaning of affinity: Cluster glycoside effects and concanavalin A
30. A general synthetic route to defined, biologically active multivalent arrays
31. Bioactive polymers
32. Tuning chemotactic responses using synthetic multivalent ligands
33. Synthetic ligands point to cell surface strategies
34. Synthesis of end-labeled multivalent ligands for exploring cell-surface-receptor-ligand interactions
35. Synthesis of cell agglutination inhibitors by aqueous ring-opening metathesis polymerization
36. Probing low affinity and multivalent interactions with surface plasmon resonance: Ligands for concanavalin A
37. Varying the size of multivalent ligands: The dependence of concanavalin A binding on neoglycopolymer length
38. Visualization of single multivalent receptor-ligand complexes by transmission electron microscopy
39. Synthesis of glycopolymers of controlled molecular weight by ring-opening metathesis polymerization using well-defined functional group tolerant ruthenium carbene catalysts
40. Well-defined ruthenium olefin metathesis catalysts: Mechanism and activity
41. Living ring-opening metathesis polymerization in aqueous media catalyzed by well-defined ruthenium carbene complexes
42. Interactions of concanavalin A with glycoproteins. A quantitative precipitation study of concanavalin A with the soybean agglutinin
43. Competitive-binding assay method based on fluorescence quenching of ligand held in close proximity by a multivalent receptor
44. Energy transfer methods for detecting molecular clusters on cell surfaces
45. Carbohydrate-protein interactions: Basis of glycobiology
46. Synthesis and some applications of chemically defined multivalent glycoconjugates
47. Synthetic multivalent ligands in the exploration of cell surface interactions
48. Chemical glycobiology
49. Can the Leonard-Jones 6-12 function replace the 10-12 form in molecular mechanics calculations
50. Structural basis of trimannoside recognition by concanavalin A
51. Molscript: A program to produce both detailed and schematic plots of protein structures
52. A fast algorithm for rendering space-filling molecule pictures
53. Contact patterns in concanavalin A agglutinated erythrocytes